Article
Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
Frontiers in immunology - 1 Jan 2021
Cortés-Hernández Arimelek, Alvarez-Salazar Evelyn Katy, Arteaga-Cruz Saúl, Rosas-Cortina Katya, Linares Nadyeli, Alberú Gómez Josefina M, Soldevila Gloria
Abstract excerpt
The adoptive transfer of alloantigen-specific regulatory T cells (alloTregs) has been proposed as a therapeutic alternative in kidney transplant recipients to the use of lifelong immunosuppressive drugs that cause serious side effects. However, the clinical application of alloTregs has been limited due to their low frequency in peripheral blood and the scarce development of efficient protocols to ensure their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
